NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that its Breast Acoustic CT™ scanner has received official classification and clearance from the United Arab Emirates (UAE) Emirates Drug Establishment (EDE) for use as a medical device in that country.
This clearance allows for the importation and distribution of our scanner through EDE-licensed medical warehouses, ensuring compliance with UAE healthcare infrastructure standards and enabling marketing to licensed healthcare facilities across the country. It also represents a significant step in QT Imaging’s global strategy and reinforces its commitment to expanding access to advanced compression-free, 3D technology offering a more comfortable and radiation-free alternative for breast imaging.
In January 2026, QT Imaging signed an exclusive distribution agreement with Al Naghi Medical Co., a leading provider of medical devices in the UAE, for the QTI scanner and the QTI Cloud Platform, establishing a $24 million revenue pipeline through 2028. According to national data cited by Elobaid et al.1, breast cancer accounts for 25% of all cancer cases in the UAE and 43% of cancers among women, underscoring the urgent need for safe and effective breast imaging solutions.
Ad Statistics
Times Displayed: 0
Times Visited: 0 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money.
“The UAE represents a highly attractive and fast-growing healthcare market, and this regulatory clearance is a pivotal milestone in our expanding global commercial presence,” said Satrajit Misra, QT Imaging’s Chief Commercial Officer. “It opens the door for commercial deployment in the region by our distributor Al Naghi Medical, positions us to build strong partnerships with leading healthcare providers and also complements our existing presence in Saudi Arabia through Gulf Medical.”
With a strong emphasis on innovation and regulatory alignment, QT Imaging is actively advancing its commercialization efforts globally. UAE regulatory clearance underscores the Company’s ability to navigate diverse regulatory environments and deliver compliant, cutting-edge solutions to international markets. Along with QT Imaging’s exclusive distribution agreement with Gulf Medical Co. for Saudi Arabia, the Company now has a commercial presence in the two largest healthcare markets in the Middle East.
About QT Imaging
QT Imaging Holdings, Inc. (Nasdaq: QTI) is a medical device company engaged in the research, development, and commercialization of innovative imaging systems using low frequency sound waves. QT Imaging Holdings, Inc. strives to improve global health outcomes. Its strategy is predicated upon the fact that medical imaging is critical to the detection, diagnosis, and treatment of disease and that it should be safe, affordable, accessible, and centered on the patient’s experience. For more information on QT Imaging Holdings, Inc., please visit the Company’s website at www.qtimaging.com and follow us on LinkedIn.
Back to HCB News
